These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34468783)

  • 1. Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes.
    Weykamp F; Herder-Wagner C; Regnery S; Hoegen P; Renkamp CK; Liermann J; Rippke C; Koerber SA; König L; Buchele C; Klüter S; Debus J; Hörner-Rieber J
    Strahlenther Onkol; 2022 Jan; 198(1):56-65. PubMed ID: 34468783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.
    Weykamp F; Hoegen P; Klüter S; Spindeldreier CK; König L; Seidensaal K; Regnery S; Liermann J; Rippke C; Koerber SA; Buchele C; Debus J; Hörner-Rieber J
    Front Oncol; 2021; 11():610637. PubMed ID: 34178616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.
    Yoon SM; Luterstein E; Chu FI; Cao M; Lamb J; Agazaryan N; Low D; Raldow A; Steinberg ML; Lee P
    Cancer Med; 2021 Sep; 10(17):5897-5906. PubMed ID: 34288538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
    Weykamp F; Hoegen P; Regnery S; Katsigiannopulos E; Renkamp CK; Lang K; König L; Sandrini E; Meixner E; Rippke C; Buchele C; Liermann J; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
    Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
    Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
    Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
    BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
    Mazzola R; Cuccia F; Figlia V; Rigo M; Nicosia L; Giaj-Levra N; Ricchetti F; Vitale C; Mantoan B; Di Paola G; De Simone A; Gurrera D; Sicignano G; Naccarato S; Ruggieri R; Alongi F
    Radiol Med; 2021 Jul; 126(7):989-997. PubMed ID: 33835309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases.
    Uder L; Nachbar M; Butzer S; Boldt J; Baumeister S; Bitzer M; Königsrainer A; Seufferlein T; Hoffmann R; Gatidis S; Nikolaou K; Zips D; Thorwarth D; Gani C; Boeke S
    Front Oncol; 2022; 12():1095633. PubMed ID: 36727060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
    Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
    Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.
    Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G
    Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes.
    Regnery S; Buchele C; Piskorski L; Weykamp F; Held T; Eichkorn T; Rippke C; Katharina Renkamp C; Klüter S; Ristau J; König L; Koerber SA; Adeberg S; Debus J; Hörner-Rieber J
    Radiother Oncol; 2022 Mar; 168():106-112. PubMed ID: 35121031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
    Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
    Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
    Morgenthaler J; Köhler C; Budach V; Sehouli J; Stromberger C; Besserer A; Trommer M; Baues C; Marnitz S
    Strahlenther Onkol; 2021 Jun; 197(6):474-486. PubMed ID: 32970164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy delivered with IMRT for oligometastatic regional lymph node metastases in hepatocellular carcinoma: a single-institutional study.
    Matoba M; Tsuchiya H; Kondo T; Ota K
    J Radiat Res; 2020 Sep; 61(5):776-783. PubMed ID: 32845298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    Ito M; Kodaira T; Koide Y; Okuda T; Mizumatsu S; Oshima Y; Takeuchi A; Mori T; Abe S; Asai A; Suzuki K
    BMC Cancer; 2020 Jun; 20(1):540. PubMed ID: 32517673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.
    Collen C; Christian N; Schallier D; Meysman M; Duchateau M; Storme G; De Ridder M
    Ann Oncol; 2014 Oct; 25(10):1954-1959. PubMed ID: 25114022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.